Marta Araujo-Castro1,2,3, Miguel Paja Fano4,5, Marga González Boillos6, Begoña Pla Peris6, Eider Pascual-Corrales7, Ana María García Cano8, Paola Parra Ramírez9, Patricia Martín Rojas-Marcos9, Jorge Gabriel Ruiz-Sanchez10, Almudena Vicente Delgado11, Emilia Gómez Hoyos12, Rui Ferreira13, Iñigo García Sanz14, Mònica Recasens Sala15, Rebeca Barahona San Millan15, María José Picón César16,17, Patricia Díaz Guardiola18, Juan Jesús García González19, Carolina M Perdomo20, Laura Manjón Miguélez21,22, Rogelio García Centeno23, Juan Carlos Percovich23, Ángel Rebollo Román24, Paola Gracia Gimeno25, Cristina Robles Lázaro26, Manuel Morales-Ruiz27, Felicia A Hanzu28. 1. Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. marta.araujo@salud.madrid.org. 2. University of Alcalá, Madrid, Spain. marta.araujo@salud.madrid.org. 3. Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain. marta.araujo@salud.madrid.org. 4. Endocrinology & Nutrition Department. OSI Bilbao-Basurto, Hospital Universitario de Basurto, Bilbao, Spain. 5. Basque Country University, Medicine Department, Bilbao, Spain. 6. Endocrinology & Nutrition Department, Hospital Universitario de Castellón, Castellón, Spain. 7. Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. 8. Biochemistry Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. 9. Endocrinology & Nutrition Department, Hospital Universitario La Paz Madrid, Madrid, Spain. 10. Endocrinology & Nutrition Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain. 11. Endocrinology & Nutrition Department, Hospital Universitario de Toledo, Toledo, Spain. 12. Endocrinology & Nutrition Department, Hospital Universitario de Valladolid, Valladolid, Spain. 13. Endocrinology & Nutrition Department, Hospital Universitario de La Princesa, Madrid, Spain. 14. General & Digestive Surgery Department, Hospital Universitario de La Princesa, Madrid, Spain. 15. Endocrinology & Nutrition Department, Institut Català de la Salut Girona, Girona, Spain. 16. Endocrinology & Nutrition Department, Hospital Universitario Virgen de la Victoria de Málaga. IBIMA, Malaga, Spain. 17. CIBEROBN, Madrid, Spain. 18. Endocrinology & Nutrition Department, Hospital Universitario Infanta Sofía, Madrid, Spain. 19. Endocrinology & Nutrition Department, Hospital Universitario Virgen de la Macarena, Sevilla, Spain. 20. Endocrinology & Nutrition Department, Clínica Universidad de Navarra, Pamplona, Spain. 21. Endocrinology & Nutrition Department, Hospital Universitario Central de Asturias, Oviedo, Spain. 22. Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain. 23. Endocrinology & Nutrition Department, Hospital Universitario Gregorio Marañón, Madrid, Spain. 24. Endocrinology & Nutrition Department, Hospital Reina Sofía, Córdoba, Spain. 25. Endocrinology & Nutrition Department, Hospital Rollo Villanueva, Zaragoza, Spain. 26. Endocrinology & Nutrition Department, Complejo Universitario de Salamanca, Salamanca, Spain. 27. Biochemistry and Molecular Genetics Department-CDB, Hospital Clinic. IDIBAPS, CIBERehd, Barcelona, Spain. 28. Endocrinology & Nutrition Department. Hospital Clinic, Barcelona, Spain. fhanzu@clinic.cat.
Abstract
OBJECTIVE: The aim of this study was to evaluate the rate of adrenal venous sampling (AVS) performance in patients with primary aldosteronism (PA), the main reasons for its non-performance, and the success and complications rate of this procedure in Spain. Moreover, the concordance between CT/MRI and AVS for PA subtyping was evaluated. METHODS: A retrospective multicenter study of PA patient follow-up in 20 Spanish tertiary hospitals between 2018-2021 was performed (SPAIN-ALDO Register). RESULTS: Of the 440 patients with PA included in the study, 153 underwent AVS (34.8%). The main reasons for not performing AVS were: patient rejection to the procedure, low catheterization rate in the center and unilateral disease based on CT/MRI. The overall success rate was 44.4% (the left adrenal vein was properly canulated in 77.8% and the right adrenal vein in 48.4%). Only 3 patients experienced minor complications. In the 45 patients with unilateral disease according to AVS, CT/MRI indicated bilateral disease or normal adrenal glands in 17. In the 23 patients with bilateral disease, CT/MRI indicated unilateral disease in 14. However, no significant differences were observed in biochemical response (P = 0.051) and hypertension resolution (P = 0.150) between patients who underwent surgery based on CT/MRI results and those who underwent surgery based on AVS results. CONCLUSION: In our setting, AVS is still an underused technique in patients with PA. The low experience and success rate in AVS partially justify these results. More training for providers and patients needs to be done to include appropriate well performed AVS in the diagnosis algorithm of PA.
OBJECTIVE: The aim of this study was to evaluate the rate of adrenal venous sampling (AVS) performance in patients with primary aldosteronism (PA), the main reasons for its non-performance, and the success and complications rate of this procedure in Spain. Moreover, the concordance between CT/MRI and AVS for PA subtyping was evaluated. METHODS: A retrospective multicenter study of PA patient follow-up in 20 Spanish tertiary hospitals between 2018-2021 was performed (SPAIN-ALDO Register). RESULTS: Of the 440 patients with PA included in the study, 153 underwent AVS (34.8%). The main reasons for not performing AVS were: patient rejection to the procedure, low catheterization rate in the center and unilateral disease based on CT/MRI. The overall success rate was 44.4% (the left adrenal vein was properly canulated in 77.8% and the right adrenal vein in 48.4%). Only 3 patients experienced minor complications. In the 45 patients with unilateral disease according to AVS, CT/MRI indicated bilateral disease or normal adrenal glands in 17. In the 23 patients with bilateral disease, CT/MRI indicated unilateral disease in 14. However, no significant differences were observed in biochemical response (P = 0.051) and hypertension resolution (P = 0.150) between patients who underwent surgery based on CT/MRI results and those who underwent surgery based on AVS results. CONCLUSION: In our setting, AVS is still an underused technique in patients with PA. The low experience and success rate in AVS partially justify these results. More training for providers and patients needs to be done to include appropriate well performed AVS in the diagnosis algorithm of PA.
Authors: Gian Paolo Rossi; Marlena Barisa; Bruno Allolio; Richard J Auchus; Laurence Amar; Debbie Cohen; Christoph Degenhart; Jaap Deinum; Evelyn Fischer; Richard Gordon; Ralph Kickuth; Gregory Kline; Andre Lacroix; Steven Magill; Diego Miotto; Mitsuhide Naruse; Tetsuo Nishikawa; Masao Omura; Eduardo Pimenta; Pierre-François Plouin; Marcus Quinkler; Martin Reincke; Ermanno Rossi; Lars Christian Rump; Fumitoshi Satoh; Leo Schultze Kool; Teresa Maria Seccia; Michael Stowasser; Akiyo Tanabe; Scott Trerotola; Oliver Vonend; Jiri Widimsky; Kwan-Dun Wu; Vin-Cent Wu; Achille Cesare Pessina Journal: J Clin Endocrinol Metab Date: 2012-03-07 Impact factor: 5.958
Authors: Oliver Vonend; Nora Ockenfels; Xing Gao; Bruno Allolio; Katharina Lang; Knut Mai; Ivo Quack; Andreas Saleh; Christoph Degenhart; Jochen Seufert; Lysann Seiler; Felix Beuschlein; Marcus Quinkler; Petr Podrabsky; Martin Bidlingmaier; Reinhard Lorenz; Martin Reincke; Lars Christian Rump Journal: Hypertension Date: 2011-03-07 Impact factor: 10.190
Authors: Martin Reincke; Irina Bancos; Paolo Mulatero; Ute I Scholl; Michael Stowasser; Tracy Ann Williams Journal: Lancet Diabetes Endocrinol Date: 2021-12 Impact factor: 32.069
Authors: Silvia Monticone; Fumitoshi Satoh; Anna S Dietz; Remi Goupil; Katharina Lang; Francesca Pizzolo; Richard D Gordon; Ryo Morimoto; Martin Reincke; Michael Stowasser; Paolo Mulatero Journal: Hypertension Date: 2015-11-16 Impact factor: 10.190
Authors: John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young Journal: J Clin Endocrinol Metab Date: 2016-03-02 Impact factor: 5.958
Authors: Paolo Mulatero; Silvia Monticone; Jaap Deinum; Laurence Amar; Aleksander Prejbisz; Maria-Christina Zennaro; Felix Beuschlein; Gian Paolo Rossi; Tetsuo Nishikawa; Alberto Morganti; Teresa Maria Seccia; Yen-Hung Lin; Francesco Fallo; Jiri Widimsky Journal: J Hypertens Date: 2020-10 Impact factor: 4.844
Authors: Marlies J E Kempers; Jacques W M Lenders; Lieke van Outheusden; Gert Jan van der Wilt; Leo J Schultze Kool; Ad R M M Hermus; Jaap Deinum Journal: Ann Intern Med Date: 2009-09-01 Impact factor: 25.391
Authors: Gian Paolo Rossi; Richard J Auchus; Morris Brown; Jacques W M Lenders; Mitsuhide Naruse; Pierre Francois Plouin; Fumitoshi Satoh; William F Young Journal: Hypertension Date: 2013-11-11 Impact factor: 10.190